Article Details
Retrieved on: 2024-07-28 02:56:12
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article focuses on various institutional investors' activities around CRISPR Therapeutics AG, a gene-editing biotech company. Though fintech appears among suggested readings, the article's primary scope is biotechnology and genetic engineering, not financial technology.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here